Market revenue in 2023 | USD 26.8 million |
Market revenue in 2030 | USD 54.1 million |
Growth rate | 10.5% (CAGR from 2023 to 2030) |
Largest segment | Oem modules |
Fastest growing segment | OEM Modules |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OEM Modules |
Key market players worldwide | Masimo Corp, Smiths Group PLC, Welch Allyn, Koninklijke Philips NV, Medtronic PLC, Nonin Medical, Nihon Kohden Corp, BD, DiaMedica Therapeutics Inc, ZOLL Medical Corporation, GE HealthCare Technologies Inc Common Stock, Hamilton Thorne Ltd, Hamilton Lane Inc Class A, Mindray Medical International, Schiller Healthcare, Avante Animal Health, Ekso Bionics Holdings Inc, BPL Medical Technologies, Burtons Medical Equipment, Criticare Technologies, Edan Instruments |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to capnography devices market will help companies and investors design strategic landscapes.
Oem modules was the largest segment with a revenue share of 44.03% in 2023. Horizon Databook has segmented the Canada capnography devices market based on oem modules covering the revenue growth of each sub-segment from 2018 to 2030.
The lucrative growth can be attributed to the increasing prevalence of respiratory disorders in the country and growing geriatric population, which is more susceptible to these disorders. According to the Lung Association of Saskatchewan, COPD is one of the most common cause of hospitalization in Canada.
In 2018, around 500,000 people aged above 35 were diagnosed with COPD. The growth of this market in this region can be attributed to increase in the number of government initiatives promoting adoption of capnographs.
For instance, Canadian Agency for Drugs and Technologies (CADTH), a health technology assessment group, conducted an assessment on the cost efficiency of capnography. Following positive results, it recommended capnography as a potential realtime ETCO2 monitoring device and highlighted its importance in hospitals and prehospital settings.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada capnography devices market , including forecasts for subscribers. This country databook contains high-level insights into Canada capnography devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account